28 results
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
4 Jan 24
Other Events
4:21pm
that targets Aβ oligomers and α-synuclein oligomers Appx 50% of DLB patients have both Aβ and α-synuclein oligomers present By regulating cellular
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
12 Sep 23
Other Events
7:00am
identify neurodegeneration targets and treatments. NIH and Advocacy groups help us cost - effectively develop clinical candidates. What we offer … Targets oligomers, a pathogenic form of amyloid plaques produced early in AD Blocks toxic oligomer binding, displaces bound oligomers - protecting
8-K
EX-99.1
g113qhchlx9 n5s3a
24 Aug 23
Regulation FD Disclosure
7:00am
424B4
vas23v76
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
ygj6kv6b3f
20 Oct 22
Draft registration statement
12:00am
DEF 14A
sxn0p4eimug7n0yf
25 Apr 22
Definitive proxy
5:28pm
10-K
vvp1w0ckq y5xg6
30 Mar 22
Annual report
7:40am
10-Q
0xtmlh8dfyblwc14l9fs
17 Nov 21
Quarterly report
5:15pm
424B4
3q530nkndlxtiea 3o
12 Oct 21
Prospectus supplement with pricing info
4:11pm